Literature DB >> 12973829

Aberrant neuronal connectivity in CHL1-deficient mice is associated with altered information processing-related immediate early gene expression.

Monique Montag-Sallaz1, Andrea Baarke, Dirk Montag.   

Abstract

In humans, loss or alteration of the CHL1/CALL gene may contribute to mental impairment associated with the 3p-syndrome, caused by distal deletions of the short (p) arm of chromosome 3, and schizophrenia. Mice deficient for the Close Homologue of L1 (CHL1) show aberrant connectivity of hippocampal mossy fibers and olfactory sensory axons, suggesting participation of CHL1 in the establishment of neuronal networks. Furthermore, behavioral studies showed that CHL1-deficient mice react differently towards novel experimental environments. These data raise the hypothesis that processing of information, possibly novel versus familiar, may be altered in the absence of CHL1. To test this hypothesis, brain activities were investigated after presentation of a novel, familiar, or neutral gustatory stimulus using metabolic mapping with ((14)C)-2-deoxyglucose (2-DG) and analysis of mRNA expression of the immediate early genes (IEGs) c-fos and arg 3.1/arc by in situ hybridization. 2-DG labeling revealed only small differences between CHL1-deficient and wild-type littermate mice. In contrast, while the specific novelty-induced increase in c-fos expression was maintained in most of the brain areas analyzed, c-fos mRNA expression was similar after the novel and familiar taste in several brain areas of the CHL1-deficient mice. Furthermore, in these mutants, arg 3.1/arc expression was slightly reduced after the novel taste and increased after the familiar taste, leading to a similar arg 3.1/arc mRNA expression after both stimuli. Our results indicate that, in contrast to controls, CHL1-deficient mice might process novel and familiar information similarly and suggest that the altered neuronal connectivity in these mutants disturbs information processing at the molecular level. Copyright 2003 Wiley Periodicals, Inc. J Neurobiol 57: 67-80, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12973829     DOI: 10.1002/neu.10254

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  9 in total

1.  Comparison of interval timing behaviour in mice following dorsal or ventral hippocampal lesions with mice having δ-opioid receptor gene deletion.

Authors:  Bin Yin; Warren H Meck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-01-20       Impact factor: 6.237

2.  Close Homolog of L1 Regulates Dendritic Spine Density in the Mouse Cerebral Cortex Through Semaphorin 3B.

Authors:  Vishwa Mohan; Sarah D Wade; Chelsea S Sullivan; Michael R Kasten; Cassandra Sweetman; Rebeccah Stewart; Young Truong; Melitta Schachner; Paul B Manis; Patricia F Maness
Journal:  J Neurosci       Date:  2019-06-10       Impact factor: 6.167

Review 3.  Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation.

Authors:  Heather E Wheeler; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

4.  Chronic mild stress impairs latent inhibition and induces region-specific neural activation in CHL1-deficient mice, a mouse model of schizophrenia.

Authors:  Mona Buhusi; Daniel Obray; Bret Guercio; Mitchell J Bartlett; Catalin V Buhusi
Journal:  Behav Brain Res       Date:  2017-06-21       Impact factor: 3.332

5.  Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.

Authors:  Thomas Fernandez; Thomas Morgan; Nicole Davis; Ami Klin; Ashley Morris; Anita Farhi; Richard P Lifton; Matthew W State
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

6.  Impaired interval timing and spatial-temporal integration in mice deficient in CHL1, a gene associated with schizophrenia.

Authors:  Mona Buhusi; Ioana Scripa; Christina L Williams; Catalin V Buhusi
Journal:  Timing Time Percept       Date:  2013

7.  De novo microduplication of CHL1 in a patient with non-syndromic developmental phenotypes.

Authors:  Orazio Palumbo; Rita Fischetto; Pietro Palumbo; Francesco Nicastro; Francesco Papadia; Leopoldo Zelante; Massimo Carella
Journal:  Mol Cytogenet       Date:  2015-08-16       Impact factor: 2.009

8.  MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action.

Authors:  Keren Oved; Luba Farberov; Avial Gilam; Ifat Israel; Danielle Haguel; David Gurwitz; Noam Shomron
Journal:  Front Mol Neurosci       Date:  2017-11-02       Impact factor: 5.639

9.  CHL1 gene acts as a tumor suppressor in human neuroblastoma.

Authors:  Marzia Ognibene; Gabriella Pagnan; Danilo Marimpietri; Davide Cangelosi; Michele Cilli; Maria Chiara Benedetti; Renata Boldrini; Alberto Garaventa; Francesco Frassoni; Alessandra Eva; Luigi Varesio; Vito Pistoia; Annalisa Pezzolo
Journal:  Oncotarget       Date:  2018-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.